Home » Sun Pharmaceuticals Halol Plant Still in Trouble with FDA after New Report
Sun Pharmaceuticals Halol Plant Still in Trouble with FDA after New Report
A year after receiving a warning letter, Sun Pharmaceuticals’ Halol, India plant has been hit with another Form 483.
That warning letter, issued in December 2015, contained a litany of serious violations, including inadequate written procedures, unexplained failures of drug batches and failures to maintain a clean area in aseptic processing.
The FDA also asked for a new smoke studies, repairs of leaking ceilings and details on how the company planned to redesign its aseptic processing operation.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May